SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G
(Rule 13d-102)

INFORMATION TO BE INCLUDED IN STATEMENTS
FILED PURSUANT TO RULE 13d-1(b), (c) AND (d)
AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2(b)

(AMENDMENT NO. 1)*

AMERICAN MOLD GUARD, INC.
(Name of Issuer)

Common Stock, no par value per share
(Title of Class of Securities)

02756R102
(CUSIP Number)

December 31, 2007
(Date of Event which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:

[ ] Rule 13d-1 (b)
[X] Rule 13d-1 (c)
[ ] Rule 13d-1 (d)

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). 

CUSIP No. 02756R102
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON: Laurus Master Fund, Ltd.
 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON: 98-0337673
--------------------------------------------------------------------------------
2
 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
 (b) [X]
--------------------------------------------------------------------------------
3 SEC USE ONLY

--------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
 Cayman Islands
--------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER: 0 shares of Common Stock. *
SHARES -------------------------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER: 465,196 shares of Common Stock. *
OWNED BY -------------------------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER: 0 shares of Common Stock. *
REPORTING -------------------------------------------------------------------
PERSON 8 SHARES DISPOSITIVE POWER: 465,196 shares of Common Stock. *
--------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 465,196 shares of Common Stock
--------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
 [X]
--------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
 9.99%
--------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON
 CO, HC
--------------------------------------------------------------------------------
* Based on 4,656,623 shares of the common stock, no par value per share (the
"Shares") outstanding of American Mold Guard, Inc., a California corporation
(the "Company"), as disclosed in the Company's Annual Report on Form 10-QSB for
the fiscal quarter ended June 30, 2007. As of December 31, 2007, Calliope
Capital Corporation ("Calliope") and Valens U.S. SPV I, LLC ("VUS", and together
with Calliope, the "Investors") held (i) a warrant (the "Warrant") to acquire
1,137,010 Shares, at an exercise price of $1.93 per Share, subject to certain
adjustments, and (ii) a secured convertible term note (the "Note") in the
aggregate initial principal amount of $2,000,000, which is convertible into
Shares at a conversion rate of $1.85 per Share, subject to certain adjustments.
The Warrant and Note contain an issuance limitation prohibiting the Investors
from exercising or converting those securities to the extent that such exercise
would result in beneficial ownership by the Investors of more than 9.99% of the
Shares then issued and outstanding (the "Issuance Limitation"). The Issuance
Limitation may be waived by the Investors upon at least 61 days prior notice to
the Company and shall automatically become null and void following notice to the
Issuer of the occurrence and during the continuance of an event of default (as
defined in and pursuant to the terms of the applicable instrument) or upon
receipt by the Investors of a notice of redemption. Calliope is a wholly owned
subsidiary of Laurus Master Fund, Ltd. which is managed by Laurus Capital
Management, LLC. Valens U.S. is managed by Valens Capital Management, LLC
("VCM"). Eugene Grin and David Grin, through other entities, are the controlling
principals of Laurus Capital Management, LLC and VCM and share voting and
investment power over the securities owned by the Investors reported in this
Schedule 13G, as amended.


CUSIP No. 02756R102
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON: Calliope Capital Corporation
 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON: 57-1237865
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
 (b) [X]
--------------------------------------------------------------------------------
3 SEC USE ONLY

--------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
 Delaware
--------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER: 0 shares of Common Stock. *
SHARES -------------------------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER: 465,196 shares of Common Stock. *
OWNED BY -------------------------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER: 0 shares of Common Stock. *
REPORTING -------------------------------------------------------------------
PERSON 8 SHARES DISPOSITIVE POWER: 465,196 shares of Common Stock. *
--------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 465,196 shares of Common Stock
--------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
 [X]
--------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
 9.99%
--------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON
 CO
--------------------------------------------------------------------------------
* Based on 4,656,623 shares of the common stock, no par value per share (the
"Shares") outstanding of American Mold Guard, Inc., a California corporation
(the "Company"), as disclosed in the Company's Annual Report on Form 10-QSB for
the fiscal quarter ended June 30, 2007. As of December 31, 2007, Calliope
Capital Corporation ("Calliope") and Valens U.S. SPV I, LLC ("VUS", and together
with Calliope, the "Investors") held (i) a warrant (the "Warrant") to acquire
1,137,010 Shares, at an exercise price of $1.93 per Share, subject to certain
adjustments, and (ii) a secured convertible term note (the "Note") in the
aggregate initial principal amount of $2,000,000, which is convertible into
Shares at a conversion rate of $1.85 per Share, subject to certain adjustments.
The Warrant and Note contain an issuance limitation prohibiting the Investors
from exercising or converting those securities to the extent that such exercise
would result in beneficial ownership by the Investors of more than 9.99% of the
Shares then issued and outstanding (the "Issuance Limitation"). The Issuance
Limitation may be waived by the Investors upon at least 61 days prior notice to
the Company and shall automatically become null and void following notice to the
Issuer of the occurrence and during the continuance of an event of default (as
defined in and pursuant to the terms of the applicable instrument) or upon
receipt by the Investors of a notice of redemption. Calliope is a wholly owned
subsidiary of Laurus Master Fund, Ltd. which is managed by Laurus Capital
Management, LLC. Valens U.S. is managed by Valens Capital Management, LLC
("VCM"). Eugene Grin and David Grin, through other entities, are the controlling
principals of Laurus Capital Management, LLC and VCM and share voting and
investment power over the securities owned by the Investors reported in this
Schedule 13G, as amended.


CUSIP No. 02756R102
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON: Laurus Capital Management, LLC
 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON: 13-4150669
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
 (b) [X]
--------------------------------------------------------------------------------
3 SEC USE ONLY

--------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
 Delaware
--------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER: 0 shares of Common Stock. *
SHARES -------------------------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER: 465,196 shares of Common Stock. *
OWNED BY -------------------------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER: 0 shares of Common Stock. *
REPORTING -------------------------------------------------------------------
PERSON 8 SHARES DISPOSITIVE POWER: 465,196 shares of Common Stock. *
--------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 465,196 shares of Common Stock
--------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
 [X]
--------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
 9.99%
--------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON
 OO
--------------------------------------------------------------------------------
* Based on 4,656,623 shares of the common stock, no par value per share (the
"Shares") outstanding of American Mold Guard, Inc., a California corporation
(the "Company"), as disclosed in the Company's Annual Report on Form 10-QSB for
the fiscal quarter ended June 30, 2007. As of December 31, 2007, Calliope
Capital Corporation ("Calliope") and Valens U.S. SPV I, LLC ("VUS", and together
with Calliope, the "Investors") held (i) a warrant (the "Warrant") to acquire
1,137,010 Shares, at an exercise price of $1.93 per Share, subject to certain
adjustments, and (ii) a secured convertible term note (the "Note") in the
aggregate initial principal amount of $2,000,000, which is convertible into
Shares at a conversion rate of $1.85 per Share, subject to certain adjustments.
The Warrant and Note contain an issuance limitation prohibiting the Investors
from exercising or converting those securities to the extent that such exercise
would result in beneficial ownership by the Investors of more than 9.99% of the
Shares then issued and outstanding (the "Issuance Limitation"). The Issuance
Limitation may be waived by the Investors upon at least 61 days prior notice to
the Company and shall automatically become null and void following notice to the
Issuer of the occurrence and during the continuance of an event of default (as
defined in and pursuant to the terms of the applicable instrument) or upon
receipt by the Investors of a notice of redemption. Calliope is a wholly owned
subsidiary of Laurus Master Fund, Ltd. which is managed by Laurus Capital
Management, LLC. Valens U.S. is managed by Valens Capital Management, LLC
("VCM"). Eugene Grin and David Grin, through other entities, are the controlling
principals of Laurus Capital Management, LLC and VCM and share voting and
investment power over the securities owned by the Investors reported in this
Schedule 13G, as amended.


CUSIP No. 02756R102
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON: Valens U.S. SPV I, LLC
 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON: 20-8903266
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
 (b) [X]
--------------------------------------------------------------------------------
3 SEC USE ONLY

--------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
 Delaware
--------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER: 0 shares of Common Stock. *
SHARES -------------------------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER: 465,196 shares of Common Stock. *
OWNED BY -------------------------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER: 0 shares of Common Stock. *
REPORTING -------------------------------------------------------------------
PERSON 8 SHARES DISPOSITIVE POWER: 465,196 shares of Common Stock. *
--------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 465,196 shares of Common Stock
--------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
 [X]
--------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
 9.99%
--------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON
 OO
--------------------------------------------------------------------------------
* Based on 4,656,623 shares of the common stock, no par value per share (the
"Shares") outstanding of American Mold Guard, Inc., a California corporation
(the "Company"), as disclosed in the Company's Annual Report on Form 10-QSB for
the fiscal quarter ended June 30, 2007. As of December 31, 2007, Calliope
Capital Corporation ("Calliope") and Valens U.S. SPV I, LLC ("VUS", and together
with Calliope, the "Investors") held (i) a warrant (the "Warrant") to acquire
1,137,010 Shares, at an exercise price of $1.93 per Share, subject to certain
adjustments, and (ii) a secured convertible term note (the "Note") in the
aggregate initial principal amount of $2,000,000, which is convertible into
Shares at a conversion rate of $1.85 per Share, subject to certain adjustments.
The Warrant and Note contain an issuance limitation prohibiting the Investors
from exercising or converting those securities to the extent that such exercise
would result in beneficial ownership by the Investors of more than 9.99% of the
Shares then issued and outstanding (the "Issuance Limitation"). The Issuance
Limitation may be waived by the Investors upon at least 61 days prior notice to
the Company and shall automatically become null and void following notice to the
Issuer of the occurrence and during the continuance of an event of default (as
defined in and pursuant to the terms of the applicable instrument) or upon
receipt by the Investors of a notice of redemption. Calliope is a wholly owned
subsidiary of Laurus Master Fund, Ltd. which is managed by Laurus Capital
Management, LLC. Valens U.S. is managed by Valens Capital Management, LLC
("VCM"). Eugene Grin and David Grin, through other entities, are the controlling
principals of Laurus Capital Management, LLC and VCM and share voting and
investment power over the securities owned by the Investors reported in this
Schedule 13G, as amended.


CUSIP No. 02756R102
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON: Valens Capital Management, LLC
 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON: 20-8903345
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
 (b) [X]
--------------------------------------------------------------------------------
3 SEC USE ONLY

--------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
 Delaware
--------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER: 0 shares of Common Stock. *
SHARES -------------------------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER: 465,196 shares of Common Stock. *
OWNED BY -------------------------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER: 0 shares of Common Stock. *
REPORTING -------------------------------------------------------------------
PERSON 8 SHARES DISPOSITIVE POWER: 465,196 shares of Common Stock. *
--------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 465,196 shares of Common Stock
--------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
 [X]
--------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
 9.99%
--------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON
 OO
--------------------------------------------------------------------------------
* Based on 4,656,623 shares of the common stock, no par value per share (the
"Shares") outstanding of American Mold Guard, Inc., a California corporation
(the "Company"), as disclosed in the Company's Annual Report on Form 10-QSB for
the fiscal quarter ended June 30, 2007. As of December 31, 2007, Calliope
Capital Corporation ("Calliope") and Valens U.S. SPV I, LLC ("VUS", and together
with Calliope, the "Investors") held (i) a warrant (the "Warrant") to acquire
1,137,010 Shares, at an exercise price of $1.93 per Share, subject to certain
adjustments, and (ii) a secured convertible term note (the "Note") in the
aggregate initial principal amount of $2,000,000, which is convertible into
Shares at a conversion rate of $1.85 per Share, subject to certain adjustments.
The Warrant and Note contain an issuance limitation prohibiting the Investors
from exercising or converting those securities to the extent that such exercise
would result in beneficial ownership by the Investors of more than 9.99% of the
Shares then issued and outstanding (the "Issuance Limitation"). The Issuance
Limitation may be waived by the Investors upon at least 61 days prior notice to
the Company and shall automatically become null and void following notice to the
Issuer of the occurrence and during the continuance of an event of default (as
defined in and pursuant to the terms of the applicable instrument) or upon
receipt by the Investors of a notice of redemption. Calliope is a wholly owned
subsidiary of Laurus Master Fund, Ltd. which is managed by Laurus Capital
Management, LLC. Valens U.S. is managed by Valens Capital Management, LLC
("VCM"). Eugene Grin and David Grin, through other entities, are the controlling
principals of Laurus Capital Management, LLC and VCM and share voting and
investment power over the securities owned by the Investors reported in this
Schedule 13G, as amended.


CUSIP No. 02756R102
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON: David Grin

--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
 (b) [X]
--------------------------------------------------------------------------------
3 SEC USE ONLY

--------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
 Israel
--------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER: 0 shares of Common Stock. *
SHARES -------------------------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER: 465,196 shares of Common Stock. *
OWNED BY -------------------------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER: 0 shares of Common Stock. *
REPORTING -------------------------------------------------------------------
PERSON 8 SHARES DISPOSITIVE POWER: 465,196 shares of Common Stock. *
--------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 465,196 shares of Common Stock
--------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
 [X]
--------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
 9.99%
--------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON
 IN
--------------------------------------------------------------------------------
* Based on 4,656,623 shares of the common stock, no par value per share (the
"Shares") outstanding of American Mold Guard, Inc., a California corporation
(the "Company"), as disclosed in the Company's Annual Report on Form 10-QSB for
the fiscal quarter ended June 30, 2007. As of December 31, 2007, Calliope
Capital Corporation ("Calliope") and Valens U.S. SPV I, LLC ("VUS", and together
with Calliope, the "Investors") held (i) a warrant (the "Warrant") to acquire
1,137,010 Shares, at an exercise price of $1.93 per Share, subject to certain
adjustments, and (ii) a secured convertible term note (the "Note") in the
aggregate initial principal amount of $2,000,000, which is convertible into
Shares at a conversion rate of $1.85 per Share, subject to certain adjustments.
The Warrant and Note contain an issuance limitation prohibiting the Investors
from exercising or converting those securities to the extent that such exercise
would result in beneficial ownership by the Investors of more than 9.99% of the
Shares then issued and outstanding (the "Issuance Limitation"). The Issuance
Limitation may be waived by the Investors upon at least 61 days prior notice to
the Company and shall automatically become null and void following notice to the
Issuer of the occurrence and during the continuance of an event of default (as
defined in and pursuant to the terms of the applicable instrument) or upon
receipt by the Investors of a notice of redemption. Calliope is a wholly owned
subsidiary of Laurus Master Fund, Ltd. which is managed by Laurus Capital
Management, LLC. Valens U.S. is managed by Valens Capital Management, LLC
("VCM"). Eugene Grin and David Grin, through other entities, are the controlling
principals of Laurus Capital Management, LLC and VCM and share voting and
investment power over the securities owned by the Investors reported in this
Schedule 13G, as amended.


CUSIP No. 02756R102
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON: Eugene Grin
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
 (b) [X]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
 United States
--------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER: 0 shares of Common Stock.*
SHARES -------------------------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER: 465,196 shares of Common Stock. *
OWNED BY -------------------------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER: 0 shares of Common Stock. *
REPORTING -------------------------------------------------------------------
PERSON 8 SHARES DISPOSITIVE POWER: 465,196 shares of Common Stock. *
--------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 465,196 shares of Common Stock
--------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
 [X]
--------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
 9.99%
--------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON
 IN
--------------------------------------------------------------------------------
* Based on 4,656,623 shares of the common stock, no par value per share (the
"Shares") outstanding of American Mold Guard, Inc., a California corporation
(the "Company"), as disclosed in the Company's Annual Report on Form 10-QSB for
the fiscal quarter ended June 30, 2007. As of December 31, 2007, Calliope
Capital Corporation ("Calliope") and Valens U.S. SPV I, LLC ("VUS", and together
with Calliope, the "Investors") held (i) a warrant (the "Warrant") to acquire
1,137,010 Shares, at an exercise price of $1.93 per Share, subject to certain
adjustments, and (ii) a secured convertible term note (the "Note") in the
aggregate initial principal amount of $2,000,000, which is convertible into
Shares at a conversion rate of $1.85 per Share, subject to certain adjustments.
The Warrant and Note contain an issuance limitation prohibiting the Investors
from exercising or converting those securities to the extent that such exercise
would result in beneficial ownership by the Investors of more than 9.99% of the
Shares then issued and outstanding (the "Issuance Limitation"). The Issuance
Limitation may be waived by the Investors upon at least 61 days prior notice to
the Company and shall automatically become null and void following notice to the
Issuer of the occurrence and during the continuance of an event of default (as
defined in and pursuant to the terms of the applicable instrument) or upon
receipt by the Investors of a notice of redemption. Calliope is a wholly owned
subsidiary of Laurus Master Fund, Ltd. which is managed by Laurus Capital
Management, LLC. Valens U.S. is managed by Valens Capital Management, LLC
("VCM"). Eugene Grin and David Grin, through other entities, are the controlling
principals of Laurus Capital Management, LLC and VCM and share voting and
investment power over the securities owned by the Investors reported in this
Schedule 13G, as amended.


CUSIP No. 02756R102

Item 1(a). Name of Issuer: American Mold Guard, Inc.

Item 1(b). Address of Issuer's Principal Executive Offices:
 30200 Rancho Viejo Road, Suite G
 San Juan Capistrano, California 92675

Item 2(a). Name of Person Filing: Laurus Master Fund, Ltd.

 This Schedule 13G is also filed on behalf of Calliope Capital
 Corporation, a Delaware corporation and a wholly owned subsidiary of
 Laurus Master Fund, Ltd., Laurus Capital Management, LLC, a Delaware
 limited liability company, Valens U.S. SPV I, LLC, a Delaware limited
 liability company, Valens Capital Management, LLC, a Delaware limited
 liability company, Eugene Grin and David Grin. Laurus Capital
 Management, LLC manages Laurus Master Fund, Ltd. Valens Capital
 Management, LLC manages Valens U.S. SPV I, LLC. Eugene Grin and David
 Grin, through other entities, are the controlling principals of
 Laurus Capital Management, LLC and Valens Capital Management, LLC and
 share sole voting and investment power over the securities owned by
 Calliope Capital Corporation and Valens U.S. SPV I, LLC reported in
 this Schedule 13G (as amended). Information related to each of Laurus
 Capital Management, LLC, Valens Capital Management, LLC, Valens U.S.
 SPV I, LLC, Calliope Capital Corporation, Eugene Grin and David Grin
 is set forth on Appendix A hereto.

Item 2(b). Address of Principal Business Office or if none, Residence:
 c/o Laurus Capital Management, LLC, 335
 Madison Avenue, 10th Floor, New York, NY 10017

Item 2(c). Citizenship: Cayman Islands

Item 2(d). Title of Class of Securities: Common Stock ("Common Stock")

Item 2(e). CUSIP Number: 02756R102

Item 3. Not Applicable

Item 4. Ownership:

 (a) Amount Beneficially Owned: 465,196 shares of Common Stock

 (b) Percent of Class: 9.99%

 (c) Number of shares as to which such person has:

 (i) sole power to vote or to direct the vote: 0 shares of Common
 Stock. *

(ii) shared power to vote or to direct the vote: 465,196 shares of Common Stock. *

(iii) sole power to dispose or to direct the disposition of: 0 shares of Common Stock. *

(iv) shared power to dispose or to direct the disposition of:


465,196 shares of Common Stock. *

Item 5. Ownership of Five Percent or Less of a Class:
Not applicable

Item 6. Ownership of More than Five Percent on Behalf of Another Person:
Not applicable

Item 7. Identification and Classification of Subsidiary Which Acquired the
Securities: Not applicable (see Item 2(a))

Item 8. Identification and Classification of Members of the Group:
Not applicable (see Item 2(a))

Item 9. Notice of Dissolution of Group: Not applicable

Item 10. Certification:

By signing below, I certify to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

* Based on 4,656,623 shares of the common stock, no par value per share (the "Shares") outstanding of American Mold Guard, Inc., a California corporation (the "Company"), as disclosed in the Company's Annual Report on Form 10-QSB for the fiscal quarter ended June 30, 2007. As of December 31, 2007, Calliope Capital Corporation ("Calliope") and Valens U.S. SPV I, LLC ("VUS", and together with Calliope, the "Investors") held (i) a warrant (the "Warrant") to acquire 1,137,010 Shares, at an exercise price of $1.93 per Share, subject to certain adjustments, and (ii) a secured convertible term note (the "Note") in the aggregate initial principal amount of $2,000,000, which is convertible into Shares at a conversion rate of $1.85 per Share, subject to certain adjustments. The Warrant and Note contain an issuance limitation prohibiting the Investors from exercising or converting those securities to the extent that such exercise would result in beneficial ownership by the Investors of more than 9.99% of the Shares then issued and outstanding (the "Issuance Limitation"). The Issuance Limitation may be waived by the Investors upon at least 61 days prior notice to the Company and shall automatically become null and void following notice to the Issuer of the occurrence and during the continuance of an event of default (as defined in and pursuant to the terms of the applicable instrument) or upon receipt by the Investors of a notice of redemption. Calliope is a wholly owned subsidiary of Laurus Master Fund, Ltd. which is managed by Laurus Capital Management, LLC. Valens U.S. is managed by Valens Capital Management, LLC ("VCM"). Eugene Grin and David Grin, through other entities, are the controlling principals of Laurus Capital Management, LLC and VCM and share voting and investment power over the securities owned by the Investors reported in this Schedule 13G, as amended. 
CUSIP No. 02756R102

 SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.

 February 14, 2008
 ----------------
 Date


 LAURUS MASTER FUND, LTD.

 /s/ David Grin
 ----------------
 David Grin
 Director


CUSIP No. 02756R102

APPENDIX A

A. Name: Calliope Capital Corporation, a Delaware corporation
 Address: 335 Madison Avenue, 10th Floor
 New York, New York 10017
 Place of
 Organization: Delaware


B. Name: Laurus Capital Management, LLC, a Delaware limited
 liability company
 Address: 335 Madison Avenue, 10th Floor
 New York, New York 10017
 Place of
 Organization: Delaware

C. Name: Valens U.S. SPV I, LLC, a Delaware limited liability
 company
 Address: 335 Madison Avenue, 10th Floor
 New York, New York 10017
 Place of
 Organization: Delaware


D. Name: Valens Capital Management, LLC, a Delaware limited
 liability company
 Address: 335 Madison Avenue, 10th Floor
 New York, New York 10017
 Place of
 Organization: Delaware


E. Name: David Grin
 Business 335 Madison Avenue, 10th Floor
 Address: New York, New York 10017

 Principal Director of Laurus Master Fund, Ltd.
 Occupation: Principal of Laurus Capital Management, LLC
 Citizenship: Israel


F. Name: Eugene Grin
 Business 335 Madison Avenue, 10th Floor
 Address: New York, New York 10017

 Principal Director of Laurus Master Fund, Ltd.
 Occupation: Principal of Laurus Capital Management, LLC
 Citizenship: United States


CUSIP No. 02756R102

Each of Calliope Capital Corporation, Laurus Capital Management, LLC, Valens
U.S. SPV I, LLC, Valens Capital Management, LLC, Eugene Grin and David Grin
hereby agree, by their execution below, that the amended Schedule 13G to which
this Appendix A is attached is filed on behalf of each of them, respectively.

Calliope Capital Corporation

/s/ Eugene Grin
-----------------------------------------
 Eugene Grin
 President, Chairman, Secretary
 February 14, 2008


Laurus Capital Management, LLC

/s/ David Grin
-----------------------------------------
 David Grin
 Principal
 February 14, 2008



Valens U.S. SPV I, LLC

By: Valens Capital Management, LLC
Individually and as investment manager

/s/ David Grin
-----------------------------------------
 David Grin
 Authorized Signatory
 February 14, 2008


/s/ David Grin
-----------------------------------------
 David Grin
 February 14, 2008


/s/ Eugene Grin
-----------------------------------------
 Eugene Grin
 February 14, 2008

American Mold Guard (MM) (NASDAQ:AMGI)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more American Mold Guard (MM) Charts.
American Mold Guard (MM) (NASDAQ:AMGI)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more American Mold Guard (MM) Charts.